Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Progress in antiangiogenic gene therapy of cancer

15 Sept 2000

Abstract excerpt

BACKGROUND: Because tumors require angiogenesis for growth, inhibiting angiogenesis is a promising strategy for treating cancer patients. Although numerous endogenous angiogenesis inhibitors have been discovered, the clinical evaluation of these agents has been hindered by high dose requirements, manufacturing constraints, and relative instability of the corresponding recombinant proteins. Therefore the delivery...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis and VEGF in Cancer
Share to Cancer Research and Treatment
Share to Cancer Research and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 11002212
DOI: 10.1002/1097-0142(20000915)89:6<1181::aid-cncr1>3.0.co;2-t

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Progress in antiangiogenic gene therapy of cancerPMID 11002212Read ↗

Human Studies of Angiogenic Gene TherapySemantic proximity Read ↗

Oncogenes and angiogenesis: a way to personalize anti-angiogenic therapy?Semantic proximity Read ↗

Anti-angiogenesis therapy in cancer: current challenges and future perspectives.Semantic proximity Read ↗

Gene therapy in cancerSemantic proximity Read ↗

Clinical translation of angiogenesis inhibitorsSemantic proximity Read ↗

Angiogenesis: A Target for Cancer TherapySemantic proximity Read ↗

A new perspective on antiangiogenic antibody drug resistance: Biomarkers, mechanisms, and strategies in malignanciesSemantic proximity Read ↗

Angiogenesis in Ischemic DiseaseSemantic proximity Read ↗

What "helps" tumors evade vascular targeting treatment?Semantic proximity Read ↗

Antisense Oligonucleotides Targeting Angiogenic Factors as Potential Cancer TherapeuticsSemantic proximity Read ↗

Are tumours angiogenesis-dependent?Semantic proximity Read ↗

Tumor suppression through angiogenesis inhibition.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.